Iren Horkayne-Szakaly Selected Research

Rituximab (Mabthera)

9/2014

Novel assessment tools to evaluate clinical and laboratory responses in a subset of patients enrolled in the Rituximab in Myositis trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Iren Horkayne-Szakaly Research Topics

Disease

3	Astrocytoma (Pilocytic Astrocytoma) 12/2013 - 08/2010
3	Neoplasms (Cancer) 12/2013 - 08/2010
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2017 - 09/2014
2	Dermatomyositis (Dermatopolymyositis) 01/2017 - 09/2014
2	Glioma (Gliomas) 12/2013 - 08/2010
1	COVID-19 11/2022
1	Leukocytosis (Pleocytosis) 01/2022
1	Muscular Diseases (Myopathy) 12/2020
1	Contracture 05/2019
1	Sickle Cell Trait 01/2018
1	Rhabdomyolysis 01/2018
1	Hematuria 01/2018
1	Leukoencephalopathies 09/2016
1	Posterior Leukoencephalopathy Syndrome 09/2016
1	Cicatrix (Scar) 01/2016
1	Nervous System Diseases (Neurological Disorders) 01/2016
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2016
1	Blast Injuries 11/2014
1	Opiate Overdose 11/2014
1	Diffuse Axonal Injury 11/2014
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 11/2014
1	Polymyositis 09/2014
1	Neurofibromatoses (Neurofibromatosis) 12/2013
1	Cowchock syndrome 12/2012
1	Optic Nerve Glioma 09/2012
1	Brain Neoplasms (Brain Tumor) 03/2011
1	Medulloblastoma 03/2011
1	Leukemia 08/2010
1	Central Nervous System Neoplasms 08/2010
1	Residual Neoplasm 08/2010
1	Carcinogenesis 08/2010

Drug/Important Bio-Agent (IBA)

2	Mitogen-Activated Protein KinasesIBA 12/2013 - 09/2012
2	ParaffinIBA 09/2012 - 03/2011
2	Formaldehyde (Formol)FDA Link 09/2012 - 03/2011
1	Complement System Proteins (Complement)IBA 11/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	2,3-Diphosphoglycerate (2,3 Bisphosphoglycerate)IBA 01/2022
1	mitapivatIBA 01/2022
1	Myosins (Myosin)IBA 12/2020
1	Sickle HemoglobinIBA 01/2018
1	Oxidoreductases (Dehydrogenase)IBA 01/2017
1	AutoantibodiesIBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 01/2017
1	Methotrexate (Mexate)FDA LinkGeneric 09/2016
1	Opiate AlkaloidsIBA 01/2016
1	Amyloid (Amyloid Fibrils)IBA 11/2014
1	Proteins (Proteins, Gene)FDA Link 11/2014
1	Rituximab (Mabthera)FDA Link 09/2014
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2013
1	ridaforolimusIBA 12/2013
1	TOR Serine-Threonine KinasesIBA 12/2013
1	Mechanistic Target of Rapamycin Complex 2IBA 12/2013
1	Apoptosis Inducing FactorIBA 12/2012
1	DNA (Deoxyribonucleic Acid)IBA 03/2011
1	Tumor Biomarkers (Tumor Markers)IBA 08/2010
1	NestinIBA 08/2010
1	WT1 ProteinsIBA 08/2010

Therapy/Procedure

2	Therapeutics 05/2019 - 09/2014
1	Immunotherapy 08/2010